thiophenes has been researched along with Hypercholesterolemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreiro, EJ; Brito, FC; Fraga, CA; Kummerle, AE; Marques, EB; Motta, NA; Scaramello, CB | 1 |
| Bäck, M; Brink, C; Foudi, N; Louedec, L; Michel, JB; Norel, X; Rienzo, M | 1 |
| Ait-Mokhtar, O; Barnay, P; Bonello, L; Bonello, R; Cabassome, E; Camilleri, E; Camoin-Jau, L; Cheneau, E; Collet, F; de Labriolle, A; Dignat-George, F; Jouve, B; Maillard, L; Mancini, J; Paganelli, F; Pansieri, M; Peyre, JP; Rossi, P; Wittenberg, O | 1 |
| Belmadani, S; Boulares, AH; Datta, R; Fallon, K; Hans, CP; Naura, A; Oumouna-Benachour, K; Suzuki, Y; Woods, C | 1 |
| Denes, R; Lehmann, R; Lusztig, G; Nienhaus, R; Sanatger, RM; Steinbach, T | 1 |
1 trial(s) available for thiophenes and Hypercholesterolemia
| Article | Year |
|---|---|
High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Blood Platelets; Coronary Thrombosis; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Phosphoproteins; Piperazines; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; ROC Curve; Sensitivity and Specificity; Stents; Thiophenes | 2011 |
4 other study(ies) available for thiophenes and Hypercholesterolemia
| Article | Year |
|---|---|
In vivo effect of LASSBio-785, a lipid-lowering and anti-inflammatory agent, on cardiac Ca(2+)-ATPases from hypercholesterolemic rats.
Topics: Animals; Calcium-Transporting ATPases; Disease Models, Animal; Hydrazones; Hypercholesterolemia; Male; Myocardium; Rats; Rats, Wistar; Thiophenes | 2015 |
Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Cholesterol; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Epoprostenol; Hypercholesterolemia; Indomethacin; Male; Norepinephrine; Rabbits; Thiophenes; Vasoconstriction; Vasoconstrictor Agents | 2009 |
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Topics: Active Transport, Cell Nucleus; Animals; Aortic Diseases; Apolipoproteins E; Apoptosis; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Cholesterol; Collagen; Crosses, Genetic; Diet, Atherogenic; Drug Evaluation, Preclinical; Foam Cells; Gene Expression Regulation; Genotype; Hydrogen Peroxide; Hypercholesterolemia; Hypertriglyceridemia; Isoquinolines; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; NF-kappa B; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Specific Pathogen-Free Organisms; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Triglycerides | 2007 |
Alteration of chromatin in early experimental arteriosclerosis.
Topics: Animals; Arteriosclerosis; Chromatin; Diabetes Mellitus, Experimental; Hypercholesterolemia; Rabbits; Rats; Thiophenes; Time Factors | 1980 |